Catalyst Pharmaceuticals
Logotype for Catalyst Pharmaceuticals Inc

Catalyst Pharmaceuticals (CPRX) investor relations material

Catalyst Pharmaceuticals has been delisted

Catalyst Pharmaceuticals EGM 2026 summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Catalyst Pharmaceuticals Inc
EGM 2026 summary8 Jul, 2026

Opening remarks and agenda

  • Meeting commenced with instructions for participation and a welcome from the board chair.

  • Agenda included voting on three specific proposals as outlined in the proxy statement.

Board and executive committee updates

  • Introductions of all board members and executive officers were made at the start of the meeting.

Corporate governance

  • The chairperson was authorized to preside and set meeting procedures per the company's bylaws.

  • The record date for voting was set as June 3, 2026, and all required notices and proxy materials were confirmed as mailed.

  • Inspector of Election was appointed and sworn in, with responsibilities for vote canvassing and reporting.

  • Quorum was confirmed with a majority of shares represented.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
Research faster. Power your platform.
Catalyst Pharmaceuticals
Cover every name on your watchlist this earnings season.
Automations, AI chat, and live calls across 16,000+ companies.
Book demo

AI chat

Ask anything. Verify everything.

Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn more

Automations

Zero in on what matters

Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more

Live audio & transcripts

Be first

Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more

Quartr MCP connects your AI environment to 17K+ public companies

Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more

Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.

Jamie Ross

Investment Manager, GAM Investments

GAM
GAM

Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.

Tom O'Hara

Investment Director

Ciena
Ciena

Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.

Gregg Lampf

VP of Investor Relations

Frequently asked questions

Catalyst Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare neurological and neuromuscular diseases. The company's portfolio includes treatments designed to address conditions such as Lambert-Eaton Myasthenic Syndrome (LEMS) and other disorders that have limited treatment options. The company is headquartered in Coral Gables, Florida, and its shares are listed on the NASDAQ.